Corrigendum to: Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case-controlled study
QJM
.
2023 Sep 12;116(8):733.
doi: 10.1093/qjmed/hcaa266.
Authors
G Rojas-Marte
1
2
,
M Khalid
1
,
O Mukhtar
3
,
A T Hashmi
1
,
M A Waheed
4
,
S Ehrlich
4
,
A Aslam
4
,
S Siddiqui
1
,
C Agarwal
1
,
Y Malyshev
1
,
C Henriquez-Felipe
1
,
D Sharma
4
,
S Sharma
4
,
N Chukwuka
4
,
D C Rodriguez
1
,
S Alliu
1
,
J Le
1
,
J Shani
1
Affiliations
1
From the Department of Cardiology, Maimonides Medical Center, 4802 10th Avenue, Brooklyn, NY 11219, USA.
2
Department of Cardiology, Staten Island University Hospital-Northwell Health, 475 Seaview Avenue, Staten Island, NY 10305, USA.
3
Department of Pulmonology, Interfaith Medical Center, 1545 Atlantic Avenue, Brooklyn, NY 11213, USA.
4
Department of Internal Medicine, Maimonides Medical Center, 4802 10th Avenue, Brooklyn, NY 11219, USA.
PMID:
33447849
PMCID:
PMC8108631
DOI:
10.1093/qjmed/hcaa266
No abstract available
Publication types
Published Erratum